Career history of Nicholas N. Vahanian
Former positions of Nicholas N. Vahanian
| Companies | Position | Start | End |
|---|---|---|---|
| LUMOS PHARMA, INC. | Director/Board Member | 2015-11-12 | 2019-11-10 |
| Chief Operating Officer | 2000-12-31 | 2013-12-20 | |
| Chief Tech/Sci/R&D Officer | 2000-12-31 | 2017-11-12 | |
| Founder | 1999-06-03 | 2019-11-10 | |
| President | 2008-12-31 | - | |
| LUMOS PHARMA, INC. | President | - | 2019-09-26 |
Training of Nicholas N. Vahanian
| Virginia Commonwealth University | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| President | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
- Stock Market
- Insiders
- Nicholas N. Vahanian
- Experience
